DAVID GRAHAM to Helicobacter pylori
This is a "connection" page, showing publications DAVID GRAHAM has written about Helicobacter pylori.
Connection Strength
54.127
-
Overcoming the effects of increasing antimicrobial resistance on Helicobacter pylori therapy. Expert Rev Gastroenterol Hepatol. 2024 Nov; 18(11):705-711.
Score: 0.464
-
Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker-Based Dual, Triple, and Quadruple Regimens for First-Line Helicobacter pylori Infection Treatment: A Systematic Review and Network Meta-Analysis. Am J Gastroenterol. 2025 Apr 01; 120(4):787-798.
Score: 0.457
-
Self-Correcting Method for Highly Effective Office-Based Helicobacter pylori Therapy Using Cumulative Test of Cure Data. Helicobacter. 2024 Jul-Aug; 29(4):e13112.
Score: 0.450
-
Gastric cancer risk in autoimmune gastritis: evidence versus opinion. Gut. 2024 02 23; 73(3):555-556.
Score: 0.439
-
Helicobacter pylori. Curr Top Microbiol Immunol. 2024; 445:127-154.
Score: 0.435
-
Atrophic autoimmune gastritis: 'a muddled or misguided core concept compromises our overall comprehension of the problem'. Gut. 2023 12 07; 73(1):207-208.
Score: 0.433
-
Toward Quantification of H pylori-associated Gastric Cancer Risk: Further Evidence Supporting Development of Population-based Strategies for H pylori Eradication. Gastroenterology. 2024 02; 166(2):248-249.
Score: 0.430
-
It Is Time for a Paradigm Shift in Design, Execution, and Publishing of Comparative Helicobacter pylori Treatment Trials. Am J Gastroenterol. 2023 07 01; 118(7):1154-1156.
Score: 0.412
-
Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates. Dig Dis Sci. 2023 05; 68(5):1691-1697.
Score: 0.410
-
Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication. Expert Rev Gastroenterol Hepatol. 2023 03; 17(3):311.
Score: 0.409
-
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities. Expert Rev Gastroenterol Hepatol. 2023 Jan; 17(1):1-7.
Score: 0.406
-
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta-analysis and critical analysis. Helicobacter. 2023 Feb; 28(1):e12936.
Score: 0.403
-
Steps forward in understanding gastric cancer risk. Gut. 2023 09; 72(9):1802-1803.
Score: 0.397
-
Autoimmune gastritis: long-term natural history in na?ve Helicobacter pylori-negative patients. Gut. 2023 01; 72(1):30-38.
Score: 0.392
-
Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why. Am J Gastroenterol. 2022 04 01; 117(4):524-528.
Score: 0.385
-
Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing. Gastroenterology. 2022 06; 162(7):2095-2097.e2.
Score: 0.382
-
Diagnosis and Treatment of Helicobacter pylori Infection. Annu Rev Med. 2022 01 27; 73:183-195.
Score: 0.380
-
Modern approach to the diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther. 2022 01; 55 Suppl 1:S14-S21.
Score: 0.378
-
Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy. Gut. 2022 03; 71(3):643-650.
Score: 0.375
-
Things We Do for No Reason?: Serum Serologic Helicobacter pylori Testing. J Hosp Med. 2021 11; 16(11):691-693.
Score: 0.374
-
Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies. Gastroenterology. 2021 11; 161(5):1433-1442.e2.
Score: 0.367
-
National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical Trial. Gastroenterology. 2021 07; 161(1):342-344.e1.
Score: 0.359
-
Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship. Clin Gastroenterol Hepatol. 2022 05; 20(5):973-983.e1.
Score: 0.359
-
Molecular-based Helicobacter pylori Susceptibility Testing Is Almost Ready for Prime Time. Gastroenterology. 2021 05; 160(6):1936-1937.
Score: 0.357
-
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapy. Helicobacter. 2021 Feb; 26(1):e12773.
Score: 0.350
-
Vonoprazan-containing Helicobacter pylori triple therapies contribution to global antimicrobial resistance. J Gastroenterol Hepatol. 2021 May; 36(5):1159-1163.
Score: 0.346
-
European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners. Gut. 2021 01; 70(1):1-2.
Score: 0.346
-
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial. Ann Intern Med. 2020 06 16; 172(12):795-802.
Score: 0.337
-
Microbiome and Gastric Cancer. Dig Dis Sci. 2020 03; 65(3):865-873.
Score: 0.333
-
Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020. Gastrointest Endosc. 2019 09; 90(3):457-460.
Score: 0.322
-
Helicobacter pylori Infection. N Engl J Med. 2019 08 08; 381(6):587-588.
Score: 0.320
-
Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply. Aliment Pharmacol Ther. 2019 08; 50(3):332.
Score: 0.320
-
Reply. Clin Gastroenterol Hepatol. 2019 06; 17(7):1420.
Score: 0.309
-
Current and Future Treatment of Helicobacter pylori Infections. Adv Exp Med Biol. 2019; 1149:211-225.
Score: 0.307
-
Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2004.
Score: 0.306
-
Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2005-2006.
Score: 0.306
-
Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI. Helicobacter. 2019 Feb; 24(1):e12554.
Score: 0.305
-
The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal. Expert Rev Gastroenterol Hepatol. 2019 Jan; 13(1):17-24.
Score: 0.305
-
Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies. Expert Rev Anti Infect Ther. 2018 09; 16(9):679-687.
Score: 0.300
-
Proton pump inhibitor therapy after Helicobacter pylori eradication may increase the risk of gastric cancer. BMJ Evid Based Med. 2018 06; 23(3):111-112.
Score: 0.292
-
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018 07; 16(7):992-1002.e6.
Score: 0.291
-
Brief report: Lactobacillus bulgaricus GLB44 (Proviotic? ) plus esomeprazole for Helicobacter pylori eradication: A pilot study. Helicobacter. 2018 Apr; 23(2):e12476.
Score: 0.290
-
Editorial: Helicobacter?pylori and gastric cancer in Alaskan Natives: Time to stop studying H.?pylori and to eradicate it. Helicobacter. 2018 06; 23(3):e12478.
Score: 0.290
-
Update on the Use of Vonoprazan: A Competitive Acid Blocker. Gastroenterology. 2018 Feb; 154(3):462-466.
Score: 0.287
-
Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
Score: 0.287
-
Illusions regarding Helicobacter pylori clinical trials and treatment guidelines. Gut. 2017 12; 66(12):2043-2046.
Score: 0.281
-
Changing Trends in Stomach Cancer Throughout the World. Curr Gastroenterol Rep. 2017 Aug; 19(8):36.
Score: 0.279
-
Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran. Dig Dis Sci. 2017 08; 62(8):1890-1896.
Score: 0.275
-
It is time to rethink H. pylori therapy. J Gastrointestin Liver Dis. 2017 06; 26(2):115-117.
Score: 0.275
-
Helicobacter pylori infection and antibiotic resistance: a WHO high priority? Nat Rev Gastroenterol Hepatol. 2017 07; 14(7):383-384.
Score: 0.274
-
Treating Helicobacter pylori effectively while minimizing misuse of antibiotics. Cleve Clin J Med. 2017 Apr; 84(4):310-318.
Score: 0.272
-
Helicobacter pylori as an oncogenic pathogen, revisited. Expert Rev Mol Med. 2017 03 21; 19:e4.
Score: 0.272
-
The Toronto Helicobacter pylori Consensus in Context. Gastroenterology. 2016 07; 151(1):9-12.
Score: 0.256
-
Helicobacter pylori therapy: a paradigm shift. Expert Rev Anti Infect Ther. 2016 06; 14(6):577-85.
Score: 0.256
-
Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues. Gut. 2017 02; 66(2):384-386.
Score: 0.254
-
Role of bismuth in improving Helicobacter pylori eradication with triple therapy. Gut. 2016 May; 65(5):870-8.
Score: 0.251
-
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016 05; 150(5):1113-1124.e5.
Score: 0.251
-
Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis. World J Gastroenterol. 2015 Dec 07; 21(45):12954-62.
Score: 0.248
-
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype. Helicobacter. 2016 Apr; 21(2):85-90.
Score: 0.248
-
Helicobacter pylori: New Thoughts and Practices. Gastroenterol Clin North Am. 2015 Sep; 44(3):xv-xvi.
Score: 0.242
-
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly. Gastroenterol Clin North Am. 2015 Sep; 44(3):537-63.
Score: 0.241
-
Roadmap for elimination of gastric cancer in Korea. Korean J Intern Med. 2015 Mar; 30(2):133-9.
Score: 0.235
-
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1616-24.
Score: 0.235
-
Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology. 2015 Apr; 148(4):719-31.e3.
Score: 0.234
-
Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40 Years in Japan. Helicobacter. 2015 Jun; 20(3):192-8.
Score: 0.233
-
RE: Effects of helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst. 2014 Nov; 106(11).
Score: 0.231
-
Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol. 2014 Sep 07; 20(33):11552-9.
Score: 0.228
-
Helicobacter pylori virulence and cancer pathogenesis. Future Oncol. 2014 Jun; 10(8):1487-500.
Score: 0.224
-
History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014 May 14; 20(18):5191-204.
Score: 0.223
-
Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma. Expert Rev Anticancer Ther. 2014 Aug; 14(8):947-54.
Score: 0.223
-
Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance. Curr Pharm Des. 2014; 20(28):4510-6.
Score: 0.217
-
Evidence-based recommendations for successful Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol. 2014 Jan; 8(1):21-8.
Score: 0.216
-
Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Intern Emerg Med. 2014 Sep; 9(6):649-54.
Score: 0.215
-
Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China. Eur J Gastroenterol Hepatol. 2013 Oct; 25(10):1134-40.
Score: 0.214
-
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):177-86.e3; Discussion e12-3.
Score: 0.209
-
Helicobacter pylori infection--a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter. 2013 Oct; 18(5):338-46.
Score: 0.207
-
Towards understanding the low prevalence of Helicobacter pylori in Malays: genetic variants among Helicobacter pylori-negative ethnic Malays in the north-eastern region of Peninsular Malaysia and Han Chinese and South Indians. J Dig Dis. 2013 Apr; 14(4):196-202.
Score: 0.206
-
PCR detection of Helicobacter pylori in clinical samples. Methods Mol Biol. 2013; 943:279-87.
Score: 0.203
-
Helicobacter pylori infection in India from a western perspective. Indian J Med Res. 2012 Oct; 136(4):549-62.
Score: 0.199
-
Which Therapy for Helicobacter pylori Infection? Gastroenterology. 2012 Jul; 143(1):10-2.
Score: 0.194
-
Treatment of Helicobacter pylori in Latin America. Lancet. 2012 Feb 04; 379(9814):408; author reply 408-9.
Score: 0.190
-
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study. J Gastroenterol Hepatol. 2012 Jan; 27(1):59-61.
Score: 0.189
-
Detection of clarithromycin resistance in Helicobacter pylori following noncryogenic storage of rapid urease tests for 30 days. J Dig Dis. 2012 Jan; 13(1):54-9.
Score: 0.189
-
Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread. Saudi J Gastroenterol. 2012 Jan-Feb; 18(1):1-2.
Score: 0.189
-
Helicobacter pylori therapy demystified. Helicobacter. 2011 Oct; 16(5):343-5.
Score: 0.186
-
Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days. Helicobacter. 2011 Aug; 16(4):295-300.
Score: 0.184
-
Maintaining and shipping Helicobacter pylori on agar stabs. Helicobacter. 2011 Jun; 16(3):252-3.
Score: 0.182
-
Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol. 2011 Apr; 45(4):309-13.
Score: 0.180
-
Empiric therapies for Helicobacter pylori infections. CMAJ. 2011 Jun 14; 183(9):E506-8.
Score: 0.178
-
Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol. 2011 Feb; 8(2):79-88.
Score: 0.178
-
Helicobacter pylori infection among Aborigines (the Orang Asli) in the northeastern region of Peninsular Malaysia. Am J Trop Med Hyg. 2010 Nov; 83(5):1119-22.
Score: 0.175
-
Monoclonal stool antigen testing for diagnosing Helicobacter pylori in young children: revisited. J Pediatr Gastroenterol Nutr. 2010 Sep; 51(3):373; author reply 373-4.
Score: 0.173
-
Pharmacologic aspects of eradication therapy for Helicobacter pylori Infection. Gastroenterol Clin North Am. 2010 Sep; 39(3):465-80.
Score: 0.173
-
Helicobacter pylori infection in India from a western perspective. Indian J Med Sci. 2010 Sep; 64(9):423-40.
Score: 0.173
-
Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010 Aug; 59(8):1143-53.
Score: 0.170
-
Hyperendemic H. pylori and tapeworm infections in a U.S.-Mexico border population. Public Health Rep. 2010 May-Jun; 125(3):441-7.
Score: 0.169
-
Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J Clin Microbiol. 2010 Jul; 48(7):2550-1.
Score: 0.168
-
Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med. 2010; 49(7):633-6.
Score: 0.168
-
Clinical practice: diagnosis and evaluation of dyspepsia. J Clin Gastroenterol. 2010 Mar; 44(3):167-72.
Score: 0.167
-
CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology. 2010 May; 138(5):1836-44.
Score: 0.165
-
OLGA can guard the barn. Am J Gastroenterol. 2009 Dec; 104(12):3099; author reply 3101-2.
Score: 0.164
-
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):36-41.e1.
Score: 0.162
-
African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009 May; 10(2):77-84.
Score: 0.157
-
Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol. 2009 Mar; 47(3):738-42.
Score: 0.154
-
Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):145-8.
Score: 0.152
-
Gastritis, dyspepsia and peptic ulcer disease. Minerva Med. 2008 Jun; 99(3):323-33.
Score: 0.148
-
New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008 Jun; 5(6):321-31.
Score: 0.147
-
Gastric endoscopy in the 21st century: appropriate use of an invasive procedure in the era of non-invasive testing. Dig Liver Dis. 2008 Jul; 40(7):497-503.
Score: 0.146
-
Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes. Dig Dis Sci. 2008 Sep; 53(9):2541-9.
Score: 0.145
-
Disturbance of apoptosis and DNA synthesis by Helicobacter pylori infection of hepatocytes. Dig Dis Sci. 2008 Sep; 53(9):2532-40.
Score: 0.144
-
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs. 2008; 68(6):725-36.
Score: 0.143
-
Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter. 2007 Nov; 12 Suppl 2:64-8.
Score: 0.142
-
Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy. Ann Intern Med. 2007 Sep 18; 147(6):434-5.
Score: 0.141
-
A report card to grade Helicobacter pylori therapy. Helicobacter. 2007 Aug; 12(4):275-8.
Score: 0.139
-
Thoughts about populations with unexpected low prevalences of Helicobacter pylori infection. Trans R Soc Trop Med Hyg. 2007 Sep; 101(9):849-51.
Score: 0.139
-
One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm. Gut. 2007 Jul; 56(7):1021-3; author reply 1022-3.
Score: 0.138
-
Helicobacter pylori eradication and its effect on iron stores: a reappraisal. J Infect Dis. 2006 Sep 01; 194(5):714; author reply 715-6.
Score: 0.131
-
Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther. 2006 Sep 01; 24(5):845-50.
Score: 0.131
-
Current understandings of Helicobacter pylori, peptic ulcer and gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2006 Sep; 52(3):235-48.
Score: 0.131
-
Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointest Endosc. 2006 Nov; 64(5):686-90.
Score: 0.131
-
Natural history of gastric cancer after Helicobacter pylori eradication in Japan: after endoscopic resection, after treatment of the general population, and naturally. Helicobacter. 2006 Jun; 11(3):139-43.
Score: 0.128
-
Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am. 2006 Jun; 35(2):229-47.
Score: 0.128
-
Is there a role for sequential in sequential anti-H. pylori therapy? Gastroenterology. 2006 May; 130(6):1930-1; author reply 1931.
Score: 0.128
-
Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter. 2006 Apr; 11(2):69-74.
Score: 0.127
-
Ulcers and gastritis. Endoscopy. 2006 Jan; 38(1):2-4.
Score: 0.125
-
Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006 Jun; 55(6):775-81.
Score: 0.124
-
Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006 Jan 15; 163(2):127-34.
Score: 0.124
-
Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005 Nov; 21(6):653-9.
Score: 0.123
-
Is real-time testing for helicobacter pylori and corpus atrophy clinically useful in 2005? Endoscopy. 2005 Oct; 37(10):1006-7.
Score: 0.123
-
Smoking and Helicobacter pylori infection in a sample of U.S. adults. Epidemiology. 2005 Jul; 16(4):586-90.
Score: 0.121
-
The time to eradicate gastric cancer is now. Gut. 2005 Jun; 54(6):735-8.
Score: 0.120
-
In vivo tests of natural therapy, Tibetan yogurt or fresh broccoli, for Helicobacter pylori infection. Methods Find Exp Clin Pharmacol. 2005 Jun; 27(5):327-9.
Score: 0.120
-
B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun. 2005 May; 73(5):2999-3006.
Score: 0.119
-
Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol. 2005 May; 40(5):523-9.
Score: 0.119
-
CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol. 2005 Mar; 58(3):259-62.
Score: 0.118
-
Practical rapid, minimally invasive, reliable nonendoscopic method to obtain Helicobacter pylori for culture. Helicobacter. 2005 Feb; 10(1):1-3.
Score: 0.117
-
Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):165-8.
Score: 0.117
-
Effects of amoxicillin dosage on cure rate, gut microbiota, and?antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial. Lancet Microbe. 2025 Mar; 6(3):100975.
Score: 0.116
-
Role of Oral Yeast in Replenishing Gastric Mucosa with Yeast and Helicobacter pylori. Yeast. 2024 11; 41(11-12):645-657.
Score: 0.115
-
Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
Score: 0.114
-
Helicobacter pylori infection: diagnosis and treatment. Expert Rev Anti Infect Ther. 2004 Aug; 2(4):599-610.
Score: 0.113
-
Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States. Dig Liver Dis. 2004 Jun; 36(6):384-7.
Score: 0.112
-
Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology. 2004 Apr; 126(4):1030-43.
Score: 0.111
-
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 2024 02 23; 73(3):407-441.
Score: 0.110
-
Review article: impact of Helicobacter pylori on society-role for a strategy of 'search and eradicate'. Aliment Pharmacol Ther. 2004 Feb; 19 Suppl 1:17-21.
Score: 0.109
-
False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004 Feb; 9(1):17-27.
Score: 0.109
-
Ulcers and gastritis. Endoscopy. 2004 Jan; 36(1):42-7.
Score: 0.109
-
A pilot study evaluating high dose esomeprazole, bismuth subcitrate and amoxicillin for eradicating Helicobacter pylori infection in Iran. Helicobacter. 2024 Jan-Feb; 29(1):e13061.
Score: 0.109
-
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial). PLoS One. 2023; 18(11):e0294403.
Score: 0.108
-
Eradicating Helicobacter pylori via 13C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method. Gut. 2023 11 24; 72(12):2231-2240.
Score: 0.108
-
Detection of genomic Helicobacter pylori DNA in the blood of patients positive for the infection. Dig Liver Dis. 2003 Nov; 35(11):839-40.
Score: 0.107
-
Pilot studies of vonoprazan-containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan. Helicobacter. 2023 Dec; 28(6):e13019.
Score: 0.107
-
Controversies regarding management of Helicobacter pylori infections. Curr Opin Gastroenterol. 2023 11 01; 39(6):482-489.
Score: 0.106
-
The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials. Gastroenterology. 2003 Aug; 125(2):639; author reply 640-1.
Score: 0.106
-
High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003 Jul; 47(7):2169-78.
Score: 0.105
-
The changing epidemiology of GERD: geography and Helicobacter pylori. Am J Gastroenterol. 2003 Jul; 98(7):1462-70.
Score: 0.105
-
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003 May 15; 17(10):1229-36.
Score: 0.104
-
Changing patterns of peptic ulcer, gastro-oesophageal reflux disease and Helicobacter pylori: a unifying hypothesis. Eur J Gastroenterol Hepatol. 2003 May; 15(5):571-2.
Score: 0.104
-
Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003 May; 98(5):1005-9.
Score: 0.104
-
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023 06; 8(6):553-564.
Score: 0.104
-
Helicobacter pylori is not and never was "protective" against anything, including GERD. Dig Dis Sci. 2003 Apr; 48(4):629-30.
Score: 0.103
-
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial. Am J Gastroenterol. 2023 07 01; 118(7):1184-1195.
Score: 0.103
-
Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study. Front Immunol. 2022; 13:1049908.
Score: 0.102
-
Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003 Jan; 17(2):193-200.
Score: 0.101
-
NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med. 2002 Dec 26; 347(26):2162-4.
Score: 0.101
-
Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology. 2002 Dec; 123(6):1992-2004.
Score: 0.101
-
Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter. 2002 Dec; 7(6):349-55.
Score: 0.101
-
Urea breath testing and analysis in the primary care office. J Fam Pract. 2002 Dec; 51(12):1030-2.
Score: 0.101
-
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe. Am J Gastroenterol. 2023 02 01; 118(2):269-275.
Score: 0.100
-
Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002 Aug; 123(2):414-24.
Score: 0.099
-
Commentary: What remains to be done regarding transmission of Helicobacter pylori. Int J Epidemiol. 2002 Jun; 31(3):646-7.
Score: 0.097
-
Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol. 2002 Jun; 97(6):1365-70.
Score: 0.097
-
Role of Helicobacter pylori in gastric carcinogenesis. Gastroenterol Clin North Am. 2002 Jun; 31(2):517-35, x.
Score: 0.097
-
Helicobacter pylori in North and South America before Columbus. FEBS Lett. 2002 Apr 24; 517(1-3):180-4.
Score: 0.097
-
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter. 2002 Feb; 7(1):1-8.
Score: 0.095
-
NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci. 2002 Jan; 47(1):38-43.
Score: 0.095
-
Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying. Aliment Pharmacol Ther. 2001 Nov; 15(11):1763-7.
Score: 0.094
-
Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointest Endosc. 2001 Oct; 54(4):448-53.
Score: 0.093
-
DNA sequence analysis of rdxA and frxA from 12 pairs of metronidazole-sensitive and -resistant clinical Helicobacter pylori isolates. Antimicrob Agents Chemother. 2001 Sep; 45(9):2609-15.
Score: 0.092
-
Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome. J Clin Microbiol. 2001 Jun; 39(6):2369-70.
Score: 0.091
-
Simplified 13C-urea breath test for detection of Helicobacter pylori infection. Am J Gastroenterol. 2001 Jun; 96(6):1741-5.
Score: 0.091
-
Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter. 2001 Jun; 6(2):116-24.
Score: 0.091
-
Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001 May 14; 161(9):1217-20.
Score: 0.091
-
Isolation of Helicobacter pylori from sheep-implications for transmission to humans. Am J Gastroenterol. 2001 May; 96(5):1396-401.
Score: 0.090
-
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology. 2021 08; 161(2):495-507.e4.
Score: 0.090
-
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study. Helicobacter. 2021 Jun; 26(3):e12801.
Score: 0.090
-
Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy. Helicobacter. 2001 Mar; 6(1):66-76.
Score: 0.089
-
Ultrastructural evidence of in vivo phagocytosis of Helicobacter pylori. Ultrastruct Pathol. 2001 Mar-Apr; 25(2):159.
Score: 0.089
-
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Am J Med. 2001 Jan 08; 110(1A):58S-61S.
Score: 0.088
-
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob Agents Chemother. 2001 Jan; 45(1):306-8.
Score: 0.088
-
Ulcer and gastritis. Endoscopy. 2001 Jan; 33(1):8-15.
Score: 0.088
-
Recent Developments Pertaining to H. pylori Infection. Am J Gastroenterol. 2021 01 01; 116(1):1-3.
Score: 0.088
-
Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. Gastroenterol Clin North Am. 2000 Dec; 29(4):885-93, x.
Score: 0.088
-
Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Nov; 44(11):3203-5.
Score: 0.087
-
Antibiotic-resistant H. pylori infection and its treatment. Curr Pharm Des. 2000 Oct; 6(15):1537-44.
Score: 0.087
-
Helicobacter pylori infection in children of Texas. J Pediatr Gastroenterol Nutr. 2000 Oct; 31(4):405-10.
Score: 0.087
-
Characterization of a culture method to recover Helicobacter pylori from the feces of infected patients. Helicobacter. 2000 Sep; 5(3):165-8.
Score: 0.086
-
Helicobacter pylori. Med Clin North Am. 2000 Sep; 84(5):1125-36, viii.
Score: 0.086
-
Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021 02; 70(2):243-250.
Score: 0.086
-
Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori. Antimicrob Agents Chemother. 2000 Aug; 44(8):2133-42.
Score: 0.086
-
Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands. J Gastroenterol Hepatol. 2021 Mar; 36(3):671-679.
Score: 0.086
-
Frame-shift mutations in NAD(P)H flavin oxidoreductase encoding gene (frxA) from metronidazole resistant Helicobacter pylori ATCC43504 and its involvement in metronidazole resistance. FEMS Microbiol Lett. 2000 Jul 15; 188(2):197-202.
Score: 0.085
-
A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A. 2000 Jun 20; 97(13):7533-8.
Score: 0.085
-
Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000 Jun; 181(6):2083-6.
Score: 0.085
-
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther. 2000 Jun; 14(6):745-50.
Score: 0.085
-
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis. Helicobacter. 2020 Aug; 25(4):e12692.
Score: 0.084
-
Clarithromycin for Helicobacter pylori infection. Expert Opin Pharmacother. 2000 Mar; 1(3):507-14.
Score: 0.083
-
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment. Dig Dis Sci. 2020 12; 65(12):3639-3646.
Score: 0.083
-
Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther. 2000 Feb; 14(2):211-5.
Score: 0.083
-
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect. 2000 Feb; 124(1):91-6.
Score: 0.083
-
H. pylori in the pathogenesis of duodenal ulcer: interaction between duodenal acid load, bile, and H. pylori. Am J Gastroenterol. 2000 Jan; 95(1):87-91.
Score: 0.082
-
Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci. 2000 Jan; 45(1):68-76.
Score: 0.082
-
Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter. 2000; 5 Suppl 1:S3-9; discussion S27-31.
Score: 0.082
-
Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut. 1999 Dec; 45(6):804-11.
Score: 0.082
-
A reliable method for the simultaneous identification of H pylori and gastric metaplasia in the duodenum. J Clin Pathol. 1999 Dec; 52(12):914-6.
Score: 0.082
-
Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies. Am J Gastroenterol. 1999 Sep; 94(9):2367-72.
Score: 0.080
-
CagA status and gastric cancer unreliable serological tests produce unreliable data. Gastroenterology. 1999 Sep; 117(3):745.
Score: 0.080
-
Modified Genta triple stain for identifying Helicobacter pylori. J Clin Pathol. 1999 Sep; 52(9):693-4.
Score: 0.080
-
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents. 1999 Aug; 12(4):341-7.
Score: 0.080
-
Helicobacter pylori in sheep milk. Lancet. 1999 Jul 10; 354(9173):132.
Score: 0.080
-
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999 Jul; 37(7):2274-9.
Score: 0.080
-
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. Helicobacter. 1999 Jun; 4(2):106-12.
Score: 0.079
-
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment. Aliment Pharmacol Ther. 2019 06; 49(11):1385-1394.
Score: 0.079
-
Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection. Helicobacter. 2019 Jun; 24(3):e12583.
Score: 0.078
-
Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999 Mar; 52(3):215-8.
Score: 0.078
-
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. Aliment Pharmacol Ther. 1999 Feb; 13(2):169-72.
Score: 0.077
-
Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther. 1999 Jan; 13(1):35-42.
Score: 0.077
-
Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol. 1999 Jan; 30(1):72-7.
Score: 0.077
-
Diagnosis and management of Helicobacter pylori infection. Clin Cornerstone. 1999; 1(5):18-28.
Score: 0.077
-
Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998 Dec; 3(4):241-53.
Score: 0.076
-
Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better? J Dig Dis. 2018 Nov; 19(11):674-677.
Score: 0.076
-
Guilt by association: intestinal metaplasia does not progress to gastric cancer. Curr Opin Gastroenterol. 2018 11; 34(6):458-464.
Score: 0.076
-
H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998 Sep; 3(3):145-51.
Score: 0.075
-
A new triple stain for Helicobacter pylori suitable for the autostainer: carbol fuchsin/Alcian blue/hematoxylin-eosin. Arch Pathol Lab Med. 1998 Aug; 122(8):732-6.
Score: 0.075
-
Prevalence of Antibiotic Resistance in Helicobacter pylori: A?Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology. 2018 11; 155(5):1372-1382.e17.
Score: 0.074
-
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. Lancet Gastroenterol Hepatol. 2018 10; 3(10):698-707.
Score: 0.074
-
How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol. 1998 Apr; 93(4):553-61.
Score: 0.073
-
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. Gastroenterology. 2018 07; 155(1):67-75.
Score: 0.073
-
Histologic assessment of Helicobacter pylori status after therapy: comparison of Giemsa, Diff-Quik, and Genta stains. Mod Pathol. 1998 Mar; 11(3):288-91.
Score: 0.073
-
One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea. Dig Dis Sci. 1998 Mar; 43(3):464-7.
Score: 0.073
-
Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection. Clin Gastroenterol Hepatol. 2018 09; 16(9):1531-1532.
Score: 0.072
-
Editorial: recurrence of Helicobacter pylori infection-still the same after all these years? Authors' reply. Aliment Pharmacol Ther. 2018 01; 47(1):132-133.
Score: 0.072
-
Letter: questions regarding the diagnostic performance of serum assays for atrophic gastritis. Aliment Pharmacol Ther. 2017 12; 46(11-12):1117-1118.
Score: 0.071
-
Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. Gastroenterology. 2018 02; 154(3):612-623.e7.
Score: 0.071
-
Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997 Oct; 11(5):935-8.
Score: 0.070
-
Uses and cautions for use of polymerase chain reaction for detection of Helicobacter pylori. Dig Dis Sci. 1997 Oct; 42(10):2116-9.
Score: 0.070
-
Early diagnosis of signet ring cell carcinoma of the stomach: role of the Genta stain. J Clin Pathol. 1997 Oct; 50(10):867-8.
Score: 0.070
-
In Vivo Analysis of the Viable Microbiota and Helicobacter pylori Transcriptome in Gastric Infection and Early Stages of Carcinogenesis. Infect Immun. 2017 10; 85(10).
Score: 0.070
-
Interleukin-17C in Human Helicobacter pylori Gastritis. Infect Immun. 2017 10; 85(10).
Score: 0.070
-
Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now? Saudi J Gastroenterol. 2017 Sep-Oct; 23(5):265-267.
Score: 0.070
-
High prevalence of duodenal ulcer and gastric cancer in dyspeptic patients in Korea. Scand J Gastroenterol. 1997 Aug; 32(8):751-4.
Score: 0.070
-
Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother. 1997 Aug; 40(2):283-6.
Score: 0.070
-
Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol. 1997 Jul; 32(7):664-8.
Score: 0.069
-
Perturbations in gastric physiology in Helicobacter pylori duodenal ulcer: are they all epiphenomena? Helicobacter. 1997 Jul; 2 Suppl 1:S44-9.
Score: 0.069
-
Primary gastric MALT lymphoma: trivial condition or serious disease? Helicobacter. 1997 Jul; 2 Suppl 1:S56-60.
Score: 0.069
-
Comparison of agar gel (CLOtest) or reagent strip (PyloriTek) rapid urease tests for detection of Helicobacter pylori infection. Am J Gastroenterol. 1997 Jun; 92(6):997-9.
Score: 0.069
-
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther. 1997 Jun; 11(3):523-7.
Score: 0.069
-
Update on Helicobacter pylori research. Eradication. Eur J Gastroenterol Hepatol. 1997 Jun; 9(6):626-8.
Score: 0.069
-
Failure to isolate Helicobacter pylori from stray cats indicates that H. pylori in cats may be an anthroponosis--an animal infection with a human pathogen. J Med Microbiol. 1997 May; 46(5):372-6.
Score: 0.068
-
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017 08; 153(2):420-429.
Score: 0.068
-
Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection. Helicobacter. 1997 Mar; 2(1):44-7.
Score: 0.068
-
Autophagy-related genes in Helicobacter pylori infection. Helicobacter. 2017 Jun; 22(3).
Score: 0.067
-
Increasing role for modified bismuth-containing quadruple therapies for Helicobacter pylori eradication. Minerva Gastroenterol Dietol. 2017 06; 63(2):77-79.
Score: 0.067
-
High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1996 Dec; 10(6):1001-4.
Score: 0.067
-
The best gastric site for obtaining a positive rapid ureas test. Helicobacter. 1996 Dec; 1(4):256-9.
Score: 0.067
-
Evaluation of a new reagent strip rapid urease test for detection of Helicobacter pylori infection. Gastrointest Endosc. 1996 Nov; 44(5):519-22.
Score: 0.066
-
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017 01; 66(1):6-30.
Score: 0.066
-
Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand. Am J Gastroenterol. 1996 Oct; 91(10):2080-6.
Score: 0.066
-
Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol. 1996 Oct; 91(10):2120-4.
Score: 0.066
-
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol. 1996 Oct; 49(10):829-32.
Score: 0.066
-
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. Dig Dis Sci. 2016 11; 61(11):3215-3220.
Score: 0.066
-
Twenty-minute fasting version of the US 13C-urea breath test for the diagnosis of H. pylori infection. Helicobacter. 1996 Sep; 1(3):165-7.
Score: 0.065
-
Helicobacter pylori infection, gastritis, and the temperature of choice for hot drinks. Helicobacter. 1996 Sep; 1(3):172-4.
Score: 0.065
-
Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogot?-Colombia (2009-2014). PLoS One. 2016; 11(7):e0160007.
Score: 0.065
-
Images in clinical medicine. Helicobacter pylori in a gastric pit. N Engl J Med. 1996 Jul 25; 335(4):250.
Score: 0.065
-
Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia. Scand J Gastroenterol. 2016 Nov; 51(11):1281-7.
Score: 0.065
-
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection. J Clin Gastroenterol. 1996 Jul; 23(1):53-4.
Score: 0.065
-
Low point prevalence of peptic ulcer in normal individuals with Helicobacter pylori infection. Am J Gastroenterol. 1996 Jun; 91(6):1112-5.
Score: 0.064
-
The interaction of pH, bile, and Helicobacter pylori may explain duodenal ulcer. Am J Gastroenterol. 1996 Jun; 91(6):1135-7.
Score: 0.064
-
Helicobacter pylori and socioeconomic factors in Russia. Helicobacter. 1996 Jun; 1(2):82-7.
Score: 0.064
-
Comparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection. Am J Gastroenterol. 1996 May; 91(5):942-8.
Score: 0.064
-
Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol. 1996 Apr; 91(4):690-4.
Score: 0.064
-
Detection of Helicobacter pylori by rapid urease tests: is biopsy size a critical variable? Gastrointest Endosc. 1996 Mar; 43(3):222-4.
Score: 0.063
-
Does using a warmer influence the results of rapid urease testing for Helicobacter pylori? Gastrointest Endosc. 1996 Mar; 43(3):260-1.
Score: 0.063
-
Identification of a Latin American-specific BabA adhesin variant through whole genome sequencing of Helicobacter pylori patient isolates from Nicaragua. BMC Evol Biol. 2016 Feb 29; 16:53.
Score: 0.063
-
Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol. 1996 Feb 01; 143(3):257-62.
Score: 0.063
-
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther. 1996 Feb; 10(1):119-22.
Score: 0.063
-
Mass Eradication of Helicobacter pylorito Prevent Gastric Cancer: Theoretical and Practical Considerations. Gut Liver. 2016 Jan; 10(1):12-26.
Score: 0.062
-
Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. J Dig Dis. 2016 Jan; 17(1):20-7.
Score: 0.062
-
Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis. 1996 Jan; 24(1):37-41.
Score: 0.062
-
Confirmation of successful therapy of Helicobacter pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol. 1995 Nov; 90(11):1962-4.
Score: 0.062
-
Helicobacter pylori, duodenal ulcer, gastric cancer: tunnel vision or blinders? Ann Med. 1995 Oct; 27(5):589-94.
Score: 0.061
-
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy. Gut. 2015 Nov; 64(11):1715-20.
Score: 0.061
-
Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. Am J Gastroenterol. 1995 Sep; 90(9):1411-4.
Score: 0.061
-
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol. 1995 Sep; 90(9):1415-8.
Score: 0.061
-
Comparison of agar based media for primary isolation of Helicobacter pylori. J Clin Pathol. 1995 Aug; 48(8):714-6.
Score: 0.061
-
Restriction fragment length polymorphism in the adhesin gene hpaA of Helicobacter pylori. Am J Gastroenterol. 1995 Aug; 90(8):1282-8.
Score: 0.061
-
Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015 Sep; 64(9):1353-67.
Score: 0.060
-
Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants. Helicobacter. 2015 Oct; 20(5):321-5.
Score: 0.060
-
Helicobacter pylori in the oral cavity. A critical review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Jun; 79(6):705-9.
Score: 0.060
-
Toll-like Receptor 10 in Helicobacter pylori Infection. J Infect Dis. 2015 Nov 15; 212(10):1666-76.
Score: 0.060
-
Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis. 1995 Apr; 14(4):349-52.
Score: 0.059
-
Editorial: quadruple therapy for H. pylori eradication is better than triple therapy - authors' reply. Aliment Pharmacol Ther. 2015 Apr; 41(7):695-6.
Score: 0.059
-
Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol. 1995 Mar; 90(3):403-5.
Score: 0.059
-
Determination of Helicobacter pylori status by reverse transcription-polymerase chain reaction. Comparison with urea breath test. Dig Dis Sci. 1995 Jan; 40(1):109-13.
Score: 0.058
-
Improved allele-specific PCR assays for detection of clarithromycin and fluoroquinolone resistant of Helicobacter pylori in gastric biopsies: identification of N87I mutation in GyrA. Diagn Microbiol Infect Dis. 2015 Apr; 81(4):251-5.
Score: 0.058
-
The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol. 1994 Dec; 89(12):2196-200.
Score: 0.058
-
Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic. Hum Pathol. 2015 Jan; 46(1):129-36.
Score: 0.057
-
Age, period, and cohort effects on gastric cancer mortality. Dig Dis Sci. 2015 Feb; 60(2):514-23.
Score: 0.057
-
The gastric cardia in Helicobacter pylori infection. Hum Pathol. 1994 Sep; 25(9):915-9.
Score: 0.057
-
Clarithromycin-amoxycillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1994 Aug; 8(4):453-6.
Score: 0.057
-
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol. 1994 Aug; 89(8):1203-5.
Score: 0.057
-
Identification of the genes that contribute to lactate utilization in Helicobacter pylori. PLoS One. 2014; 9(7):e103506.
Score: 0.057
-
Helicobacter pylori infection introduces DNA double-strand breaks in host cells. Infect Immun. 2014 Oct; 82(10):4182-9.
Score: 0.057
-
Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med. 1994 Jun 15; 120(12):982-6.
Score: 0.056
-
Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut. 1994 Jun; 35(6):742-5.
Score: 0.056
-
Helicobacter pylori alcohol dehydrogenase in perspective: an interesting finding of doubtful clinical significance. Scand J Gastroenterol. 1994 Jun; 29(6):481-2.
Score: 0.056
-
Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc. 1994 May-Jun; 40(3):342-5.
Score: 0.056
-
Helicobacter pylori gastritis in HIV-infected patients: a review. Helicobacter. 2014 Oct; 19(5):323-9.
Score: 0.056
-
High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections. Helicobacter. 2014 Aug; 19(4):319-22.
Score: 0.055
-
Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1994 Apr; 8(2):259-62.
Score: 0.055
-
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J Gastroenterol. 2014 Mar 28; 20(12):3343-9.
Score: 0.055
-
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. Helicobacter. 2014 Jun; 19(3):207-13.
Score: 0.055
-
Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol. 1994 Mar; 25(3):221-6.
Score: 0.055
-
Age-dependent association among Helicobacter pylori infection, serum pepsinogen levels and immune response of children to live oral cholera vaccine CVD 103-HgR. PLoS One. 2014; 9(1):e83999.
Score: 0.054
-
Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol. 2014 Mar; 109(3):357-68.
Score: 0.054
-
Helicobacter pylori: the new bug on the (paraffin) block. Virchows Arch. 1994; 425(4):339-47.
Score: 0.054
-
Are there susceptible hosts to Helicobacter pylori infection? Scand J Gastroenterol Suppl. 1994; 205:6-10.
Score: 0.054
-
Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol. 1993 Dec; 88(12):2038-43.
Score: 0.054
-
Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA. J Infect Dis. 2014 May 01; 209(9):1452-8.
Score: 0.054
-
Minimum analysis requirements for the detection of Helicobacter pylori infection by the 13C-urea breath test. Am J Gastroenterol. 1993 Nov; 88(11):1865-9.
Score: 0.054
-
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993 Nov; 28(11):939-42.
Score: 0.054
-
Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol. 1993 Oct; 28(10):924-8.
Score: 0.053
-
Gastric mucosal hydrophobicity and Helicobacter pylori: response to antimicrobial therapy. Am J Gastroenterol. 1993 Sep; 88(9):1362-5.
Score: 0.053
-
Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogot? D.C., Colombia. J Microbiol. 2013 Aug; 51(4):448-52.
Score: 0.053
-
CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection. J Immunol. 2013 Oct 01; 191(7):3838-46.
Score: 0.053
-
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processing. Scand J Gastroenterol. 1993 Aug; 28(8):690-4.
Score: 0.053
-
Helicobacter pylori research: historical insights and future directions. Nat Rev Gastroenterol Hepatol. 2013 08; 10(8):495-500.
Score: 0.052
-
Clarithromycin for the eradication of Helicobacter pylori. J Clin Gastroenterol. 1993 Jun; 16(4):292-4.
Score: 0.052
-
Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol. 1993 Jun; 24(6):577-83.
Score: 0.052
-
DNA-DNA hybridization demonstrates apparent genetic differences between Helicobacter pylori from patients with duodenal ulcer and asymptomatic gastritis. Dig Dis Sci. 1993 Jun; 38(6):1128-31.
Score: 0.052
-
Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol. 1993 May; 6(3):281-9.
Score: 0.052
-
Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter. 2013 Oct; 18(5):373-7.
Score: 0.052
-
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth. Aliment Pharmacol Ther. 1993 Feb; 7(1):111-3.
Score: 0.051
-
Helicobacter pylori infection in dental workers: a seroepidemiology study. Am J Gastroenterol. 1992 Dec; 87(12):1728-31.
Score: 0.050
-
Review article: urease, gastric ammonium/ammonia, and Helicobacter pylori--the past, the present, and recommendations for future research. Aliment Pharmacol Ther. 1992 Dec; 6(6):659-69.
Score: 0.050
-
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71.
Score: 0.050
-
Helicobacter pylori in Hispanics: comparison with blacks and whites of similar age and socioeconomic class. Gastroenterology. 1992 Sep; 103(3):813-6.
Score: 0.050
-
Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infection. Gastroenterology. 1992 Sep; 103(3):848-54.
Score: 0.050
-
Short report: cefprozil for the eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 1992 Aug; 6(4):503-6.
Score: 0.049
-
Greater than 95% success with 14-day bismuth quadruple anti- Helicobacter pylori therapy: a pilot study in US Hispanics. Helicobacter. 2012 Oct; 17(5):382-90.
Score: 0.049
-
Gastrointestinal symptoms and Helicobacter pylori infection in school-age children residing in Porto Torres, Sardinia, Italy. Helicobacter. 2012 Oct; 17(5):369-73.
Score: 0.049
-
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012 May; 61(5):646-64.
Score: 0.048
-
Urease-associated heat shock protein of Helicobacter pylori. Infect Immun. 1992 May; 60(5):2125-7.
Score: 0.048
-
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992 May 01; 116(9):705-8.
Score: 0.048
-
Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology. 1992 May; 102(5):1557-67.
Score: 0.048
-
Vitamin C, gastritis, and gastric disease: a historical review and update. Dig Dis Sci. 2012 Oct; 57(10):2504-15.
Score: 0.048
-
Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells. Helicobacter. 2012 Jun; 17(3):193-202.
Score: 0.048
-
The role of Helicobacter pylori in recurrent, functional abdominal pain in children. Am J Gastroenterol. 1992 Mar; 87(3):347-9.
Score: 0.048
-
Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb; 102(2):493-6.
Score: 0.048
-
Sociocultural and dietary practices among Malay subjects in the north-eastern region of Peninsular Malaysia: a region of low prevalence of Helicobacter pylori infection. Helicobacter. 2012 Feb; 17(1):54-61.
Score: 0.048
-
Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J Clin Microbiol. 2012 Feb; 50(2):441-8.
Score: 0.047
-
Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. J Gastroenterol Hepatol. 2011 Nov; 26(11):1677-84.
Score: 0.047
-
The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun. 2012 Jan; 80(1):381-7.
Score: 0.047
-
Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics. 1991 Sep; 88(3):578-82.
Score: 0.046
-
Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin. Am J Gastroenterol. 1991 Sep; 86(9):1158-62.
Score: 0.046
-
Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991 Aug 15; 115(4):266-9.
Score: 0.046
-
Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci. 1991 Aug; 36(8):1084-8.
Score: 0.046
-
Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am J Physiol Gastrointest Liver Physiol. 2011 Oct; 301(4):G601-11.
Score: 0.046
-
Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991 Jun; 100(6):1495-501.
Score: 0.045
-
Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology. 1991 Jun; 100(6):1571-5.
Score: 0.045
-
Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. Gastroenterology. 1991 Jun; 100(6):1653-7.
Score: 0.045
-
Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol. 1991 Jun; 86(6):735-7.
Score: 0.045
-
Double-blind randomized trial of quadruple sequential Helicobacter pylori eradication therapy in asymptomatic infected children in El Paso, Texas. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):319-25.
Score: 0.045
-
Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr. 2011 Mar; 52(3):326-32.
Score: 0.045
-
Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis. 2011 Mar 01; 203(5):726-35.
Score: 0.044
-
Characterization of the Helicobacter pylori urease and purification of its subunits. Microb Pathog. 1991 Jan; 10(1):15-26.
Score: 0.044
-
Helicobacter pylori and Zollinger-Ellison syndrome. Dig Dis Sci. 1991 Jan; 36(1):15-8.
Score: 0.044
-
Helicobacter pylori catalase. J Gen Microbiol. 1991 Jan; 137(1):57-61.
Score: 0.044
-
Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010 Dec; 15(6):486-90.
Score: 0.044
-
Incidence of esophageal carcinoma among Malays in North-Eastern Peninsular Malaysia: an area with an exceptionally low prevalence of Helicobacter pylori infection. Dig Dis Sci. 2011 May; 56(5):1438-43.
Score: 0.044
-
Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States. J Gastroenterol. 2010 Aug; 45(8):816-20.
Score: 0.042
-
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010 May; 31(10):1104-11.
Score: 0.042
-
Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol. 2009 Nov; 47(11):3493-500.
Score: 0.040
-
Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010; 45(1):1-8.
Score: 0.040
-
homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol. 2009 Oct; 47(10):3241-5.
Score: 0.040
-
Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci. 2009 Nov; 100(11):2152-9.
Score: 0.040
-
Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol. 2009 Mar; 24(3):462-8.
Score: 0.039
-
The peopling of the Pacific from a bacterial perspective. Science. 2009 Jan 23; 323(5913):527-30.
Score: 0.039
-
Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep. 2008 Dec; 10(6):543-7.
Score: 0.038
-
Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008 Oct; 4(10):e1000180.
Score: 0.038
-
Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol. 2009 Jan; 11(1):70-82.
Score: 0.038
-
OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008 Aug; 40(8):650-8.
Score: 0.037
-
Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr. 2008 Apr; 46(4):399-402.
Score: 0.036
-
OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol. 2008 Apr; 16(2):150-4.
Score: 0.036
-
vacA i-region subtyping. Gastroenterology. 2008 Apr; 134(4):1267; author reply 1268.
Score: 0.036
-
Regulation of IL-18 in Helicobacter pylori infection. J Immunol. 2008 Jan 15; 180(2):1207-16.
Score: 0.036
-
Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt. Scand J Infect Dis. 2008; 40(9):730-3.
Score: 0.036
-
OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol. 2008 Apr; 10(4):1008-20.
Score: 0.036
-
Dramatic changes in the prevalence of Helicobacter pylori infection during childhood: a 10-year follow-up study in Russia. J Pediatr Gastroenterol Nutr. 2007 Oct; 45(4):428-32.
Score: 0.035
-
Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol. 2007 Oct; 9(10):2457-69.
Score: 0.034
-
Genetic analysis of Helicobacter pylori strain populations colonizing the stomach at different times postinfection. J Bacteriol. 2007 May; 189(10):3834-45.
Score: 0.034
-
An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007 Feb 22; 445(7130):915-918.
Score: 0.034
-
Pattern of transcription factor activation in Helicobacter pylori-infected Mongolian gerbils. Gastroenterology. 2007 Mar; 132(3):1024-38.
Score: 0.033
-
Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem. 2007 Mar 02; 282(9):6242-54.
Score: 0.033
-
Importance of atrophic gastritis in diagnostics and prevention of gastric cancer: application of plasma biomarkers. Scand J Gastroenterol. 2007 Jan; 42(1):2-10.
Score: 0.033
-
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007 Jun; 56(6):772-81.
Score: 0.033
-
Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):49-58.
Score: 0.033
-
Point-of-care Helicobacter pylori urine antibody detection in a multi-ethnic adult population in the United States. Transl Res. 2006 Jul; 148(1):13-8.
Score: 0.032
-
Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res. 2006 May 15; 66(10):5111-20.
Score: 0.032
-
Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol. 2006 Mar 01; 176(5):3000-9.
Score: 0.032
-
Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):306-14.
Score: 0.032
-
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301.
Score: 0.031
-
Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun. 2005 Nov; 73(11):7602-12.
Score: 0.031
-
Atrophic gastritis in young children and adolescents. J Clin Pathol. 2005 Nov; 58(11):1189-93.
Score: 0.031
-
Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell. 2005 Oct; 16(10):4954-66.
Score: 0.030
-
Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005 Jun 20; 115(3):463-9.
Score: 0.030
-
Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model. Gut. 2005 May; 54(5):584-90.
Score: 0.030
-
Effect of different organic acids (citric, malic and ascorbic) on intragastric urease activity. Aliment Pharmacol Ther. 2005 May 01; 21(9):1145-8.
Score: 0.030
-
Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9.
Score: 0.030
-
Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005 Apr; 128(4):833-48.
Score: 0.030
-
Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005 Mar; 25(1):197-222.
Score: 0.029
-
Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother. 2005 Feb; 49(2):578-83.
Score: 0.029
-
A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck. 2005 Jan; 27(1):22-7.
Score: 0.029
-
Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004 Oct; 9(5):453-9.
Score: 0.029
-
The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. Dig Dis Sci. 2004 Sep; 49(9):1551-5.
Score: 0.028
-
Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells. J Clin Microbiol. 2004 Aug; 42(8):3518-24.
Score: 0.028
-
Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Aliment Pharmacol Ther. 2004 May 15; 19(10):1051-61.
Score: 0.028
-
Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol. 2004 May; 42(5):2279-81.
Score: 0.028
-
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. Helicobacter. 2003 Dec; 8(6):626-42.
Score: 0.027
-
Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Clin Diagn Lab Immunol. 2003 Nov; 10(6):1025-8.
Score: 0.027
-
Cyclooxygenase expression during Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci. 2003 Nov; 48(11):2139-46.
Score: 0.027
-
Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan. Clin Infect Dis. 2003 Oct 15; 37(8):1067-72.
Score: 0.027
-
Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol. 2003 Jul; 41(7):3336-8.
Score: 0.026
-
Helicobacter pylori and hetertopic gastric mucosa in the upper esophagus (the inlet patch). Am J Gastroenterol. 2003 Jun; 98(6):1266-70.
Score: 0.026
-
Detection of Chlamydiae pneumoniae but not Helicobacter pylori DNA in atherosclerosis plaques. Dig Dis Sci. 2003 May; 48(5):945-51.
Score: 0.026
-
Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter. 2003 Apr; 8(2):142-8.
Score: 0.026
-
Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol. 2003 Apr; 41(4):1480-5.
Score: 0.026
-
Traces of human migrations in Helicobacter pylori populations. Science. 2003 Mar 07; 299(5612):1582-5.
Score: 0.026
-
[Helicobacter pylori infection in a group of symptomatic and asymptomatic children and adolescents in the Czech Republic]. Cas Lek Cesk. 2003 Feb; 142(2):102-5.
Score: 0.026
-
New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol. 2002 Dec; 40(12):4753-6.
Score: 0.025
-
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002 Dec; 123(6):1793-803.
Score: 0.025
-
Genomic fingerprinting and genotyping of Helicobacter pylori strains from patients with duodenal ulcer or gastric cancer from different geographic regions. Dig Dis Sci. 2002 Nov; 47(11):2512-8.
Score: 0.025
-
Pathogenesis and therapy of gastric and duodenal ulcer disease. Med Clin North Am. 2002 Nov; 86(6):1447-66, viii.
Score: 0.025
-
Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol. 2002 Sep; 97(9):2231-8.
Score: 0.025
-
Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology. 2002 Aug; 123(2):542-53.
Score: 0.025
-
Risk Factors Associated with Helicobacter pylori Infection among Children in a Defined Geographic Area. Clin Infect Dis. 2002 Aug 01; 35(3):240-5.
Score: 0.025
-
Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci. 2002 Jul; 47(7):1638-43.
Score: 0.024
-
Helicobacter pylori infection in asymptomatic children: impact of epidemiologic factors on accuracy of diagnostic tests. J Pediatr Gastroenterol Nutr. 2002 Jul; 35(1):59-63.
Score: 0.024
-
Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol. 2002 Jun; 40(6):2244-6.
Score: 0.024
-
Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Am J Gastroenterol. 2002 Apr; 97(4):857-60.
Score: 0.024
-
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002 Mar 16; 359(9310):931-5.
Score: 0.024
-
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002 Feb; 16(2):167-80.
Score: 0.024
-
Helicobacter pylori infection and the use of NSAIDs. Best Pract Res Clin Gastroenterol. 2001 Oct; 15(5):775-85.
Score: 0.023
-
Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001 Sep; 54(9):679-83.
Score: 0.023
-
The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol. 2001 Jun; 54(6):456-60.
Score: 0.023
-
Helicobacter pylori infection in preschool and school-aged minority children: effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis. 2001 May 15; 32(10):1387-92.
Score: 0.023
-
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother. 2001 Apr; 47(4):459-61.
Score: 0.022
-
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. Aliment Pharmacol Ther. 2001 Apr; 15(4):513-8.
Score: 0.022
-
Stable amoxicillin resistance in Helicobacter pylori. Helicobacter. 2001 Mar; 6(1):79.
Score: 0.022
-
Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020 12; 69(12):2093-2112.
Score: 0.022
-
Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000. Curr Pharm Des. 2000 Oct; 6(15):1503-14.
Score: 0.022
-
Helicobacter pylori infection in asymptomatic children: comparison of diagnostic tests. Helicobacter. 2000 Sep; 5(3):155-9.
Score: 0.022
-
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother. 2000 Aug; 44(8):2214-6.
Score: 0.021
-
The gastric cardia in gastro-oesophageal disease. J Clin Pathol. 2000 Aug; 53(8):619-25.
Score: 0.021
-
Quantitative RT-PCR analysis of multiple genes encoding putative metronidazole nitroreductases from Helicobacter pylori. Int J Antimicrob Agents. 2000 Jun; 15(1):31-6.
Score: 0.021
-
Diabetes mellitus and Helicobacter pylori infection. Nutrition. 2000 Jun; 16(6):407-10.
Score: 0.021
-
Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection. J Clin Microbiol. 2000 May; 38(5):1971-3.
Score: 0.021
-
Sustained increase in gastric antral epithelial cell proliferation despite cure of Helicobacter pylori infection. Am J Gastroenterol. 2000 Apr; 95(4):930-5.
Score: 0.021
-
Pathogenesis of duodenal ulcer disease: the rest of the story. Baillieres Best Pract Res Clin Gastroenterol. 2000 Feb; 14(1):97-107.
Score: 0.021
-
Are genetic influences on peptic ulcer dependent or independent of genetic influences for Helicobacter pylori infection? Arch Intern Med. 2000 Jan 10; 160(1):105-9.
Score: 0.021
-
Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera? or Lactobacillus reuteri for treatment na?ve or for retreatment of Helicobacter pylori. Two randomized pilot studies. Helicobacter. 2019 Dec; 24(6):e12659.
Score: 0.020
-
Normalizing results of 13C-urea breath testing for CO2 production rates in children. J Pediatr Gastroenterol Nutr. 1999 Sep; 29(3):297-301.
Score: 0.020
-
Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori. Helicobacter. 1999 Sep; 4(3):154-61.
Score: 0.020
-
The differential diagnosis of early gastric mucosa-associated lymphoma: polymerase chain reaction and paraffin section immunophenotyping. Mod Pathol. 1999 Sep; 12(9):885-93.
Score: 0.020
-
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 1999 Aug; 117(2):342-9.
Score: 0.020
-
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999 Jul 20; 131(2):88-95.
Score: 0.020
-
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019 09; 68(9):1545-1575.
Score: 0.020
-
Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins. Antimicrob Agents Chemother. 1999 Jul; 43(7):1803-4.
Score: 0.020
-
Proinflammatory activation of neutrophils and monocytes by Helicobacter pylori in patients with different clinical presentations. Infect Immun. 1999 Jun; 67(6):3171-4.
Score: 0.020
-
High prevalence of Helicobacter pylori infection in shepherds. Dig Dis Sci. 1999 Jun; 44(6):1161-4.
Score: 0.020
-
High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial. Helicobacter. 2019 Aug; 24(4):e12596.
Score: 0.020
-
Citric acid as the test meal for the 13C-urea breath test. Am J Gastroenterol. 1999 May; 94(5):1214-7.
Score: 0.020
-
Molecular relationships of Helicobacter pylori strains in a family with gastroduodenal disease. Am J Gastroenterol. 1999 Feb; 94(2):364-8.
Score: 0.019
-
Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community. Clin Infect Dis. 1999 Feb; 28(2):279-82.
Score: 0.019
-
Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother. 1999 Jan; 43(1):47-54.
Score: 0.019
-
Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch. 1998 Nov; 433(5):419-26.
Score: 0.019
-
Co-twin study of the effect of environment and dietary elements on acquisition of Helicobacter pylori infection. Am J Epidemiol. 1998 Oct 15; 148(8):793-7.
Score: 0.019
-
Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis. 1998 Sep; 178(3):717-21.
Score: 0.019
-
The effect of galE gene inactivation on lipopolysaccharide profile of Helicobacter pylori. Curr Microbiol. 1998 Aug; 37(2):144-8.
Score: 0.019
-
Intestinal metaplasia with adherent Helicobacter pylori: a hybrid epithelium with both gastric and intestinal features. Hum Pathol. 1998 Aug; 29(8):846-50.
Score: 0.019
-
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis. 1998 Jul; 27(1):84-9.
Score: 0.019
-
Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1998 Jul; 12(7):635-9.
Score: 0.019
-
REP-PCR fragments as biomarkers for differentiating gastroduodenal disease-specific Helicobacter pylori strains. Dig Dis Sci. 1998 May; 43(5):980-7.
Score: 0.018
-
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2018 09; 16(9):1427-1433.
Score: 0.018
-
Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol. 1997 Nov; 108(5):504-9.
Score: 0.018
-
Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun. 1997 Oct; 65(10):4229-35.
Score: 0.018
-
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea. Aliment Pharmacol Ther. 1997 Oct; 11(5):939-42.
Score: 0.018
-
Systematic review with meta-analysis: the global recurrence rate of Helicobacter pylori. Aliment Pharmacol Ther. 2017 11; 46(9):773-779.
Score: 0.018
-
Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology. 1997 Sep; 113(3):746-54.
Score: 0.018
-
Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1997 Jun; 11(3):529-32.
Score: 0.017
-
Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol. 1997 Jan; 32(1):22-7.
Score: 0.017
-
Histological features do not define NSAID-induced gastritis. Hum Pathol. 1996 Dec; 27(12):1348-54.
Score: 0.017
-
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Helicobacter. 1996 Dec; 1(4):243-50.
Score: 0.017
-
Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology. 1996 Nov; 111(5):1206-11.
Score: 0.017
-
Detection of Helicobacter pylori in paraffin-embedded gastric biopsy specimens by in situ hybridization. Am J Clin Pathol. 1996 Sep; 106(3):305-11.
Score: 0.016
-
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1996 Aug; 10(4):617-21.
Score: 0.016
-
Helicobacter pylori in the drinking water in Peru. Gastroenterology. 1996 Apr; 110(4):1031-5.
Score: 0.016
-
Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. Endoscopy. 1996 Feb; 28(2):229-33.
Score: 0.016
-
Extract of Helicobacter pylori induces neutrophils to injure endothelial cells and contains antielastase activity. Gastroenterology. 1996 Jan; 110(1):21-9.
Score: 0.016
-
Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol. 1996 Jan; 27(1):35-41.
Score: 0.016
-
Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann Med. 1995 Oct; 27(5):595-9.
Score: 0.015
-
Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun. 1995 Jun; 63(6):2213-20.
Score: 0.015
-
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Apr; 9(2):209-12.
Score: 0.015
-
Changing prevalence of Helicobacter pylori infection and peptic ulcer among dyspeptic Sardinian patients. Intern Emerg Med. 2015 Oct; 10(7):787-94.
Score: 0.015
-
The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter. 2015 Aug; 20(4):305-15.
Score: 0.015
-
Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
Score: 0.014
-
Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells, and platelets. Gastroenterology. 1994 Jul; 107(1):70-9.
Score: 0.014
-
Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology. 1993 Nov; 105(5):1431-40.
Score: 0.013
-
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol. 1993 Nov; 88(11):1860-4.
Score: 0.013
-
Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol. 1993 Apr; 31(4):783-7.
Score: 0.013
-
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol. 1993 Feb; 175(3):674-83.
Score: 0.013
-
Transmission of Helicobacter pylori infection. Studies in families of healthy individuals. Scand J Gastroenterol. 1991 Sep; 26(9):927-32.
Score: 0.012
-
Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet. 1991 Jun 22; 337(8756):1503-6.
Score: 0.011
-
Urea breath test in children: the United States prospective, multicenter study. Helicobacter. 2009 Apr; 14(2):134-40.
Score: 0.010
-
Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007 May; 56(5):631-6.
Score: 0.008
-
Improved infrared spectrophotometer for point-of-care patient 13C-urea breath testing in the primary care setting. Clin Biochem. 2005 Aug; 38(8):731-4.
Score: 0.008
-
Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils. Infect Immun. 2005 Apr; 73(4):2205-12.
Score: 0.007
-
Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am J Trop Med Hyg. 2002 Aug; 67(2):201-6.
Score: 0.006
-
Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation. 2002 Jul 23; 106(4):430-4.
Score: 0.006
-
Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol. 2001 Mar; 96(3):666-72.
Score: 0.006
-
Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000 Jun; 95(6):1431-8.
Score: 0.005
-
Reverse transcription and polymerase chain reaction amplification of rRNA for detection of Helicobacter species. J Clin Microbiol. 1992 Sep; 30(9):2295-301.
Score: 0.003